Targeting the Underlying Biology of Severe Rare Diseases🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for scynexis.com. This domain is officially recognized as Scynexis. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for scynexis.com. Scynexis currently holds an estimated domain authority score of 91/100 in the .COM namespace based on our global index mapping.".
Table of Contents
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 53Outbound Links: 2
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$975
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- scynexis.comAvailable
- scynexis.netAvailable
- scynexis.orgAvailable
- scynexis.ioTaken
- scynexis.coTaken
- scynexis.aiTaken
Official Contact & Profiles
Socials:linkedin.comtwitter.com
Content Snippets from scynexis.com
"SCYNEXIS is a clinical-stage biotechnology company developing differentiated therapies for severe rare diseases, led by SCY-770 for autosomal dominant polycystic kidney disease (ADPKD) and SCY-247 for the treatment and prevention of serious fungal infections, addressing significant unmet needs for patients with limited treatment options."
"SCYNEXIS is a clinical-stage biotechnology company developing differentiated therapies for severe rare diseases, led by SCY-770 for autosomal dominant polycystic kidney disease (ADPKD) and SCY-247 for the treatment and prevention of serious fungal infections, addressing significant unmet needs for patients with limited treatment options."
"Our strategy is built on advancing programs with validated mechanisms, well-understood regulatory pathways, and clear potential to improve patient outcomes. Following the successful development and FDA approval of ibrexafungerp (BREXAFEMME®), now licensed to GSK, we are focused on developing innovative therapies for patients facing serious and underserved diseases."
"Our pipeline targets diseases where patients continue to face limited treatment options, including autosomal dominant polycystic kidney disease (ADPKD) and invasive fungal infections, where significant unmet medical need remains."
Key Topics & Focus Areas for scynexis.com:
Our Latest Progress
By comparing scynexis.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to scynexis.com.
Frequently Asked Questions
Is scynexis.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of scynexis.com?
As of October 31, 2026, scynexis.com holds an estimated domain authority score of 46/100 based on our VisitRank tracking algorithms.
What are the top alternatives to scynexis.com?
You can find the best alternatives and similar sites to scynexis.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for scynexis.com:
sycnexis.comscnexis.comsccynexis.comscynaxis.comscynexos.comsxynexis.comsdynexis.com